Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 17;27(4):1351.
doi: 10.3390/molecules27041351.

Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease

Anna Och  1 , Marek Och  2 , Renata Nowak  1 , Dominika Podgórska  3 , Rafał Podgórski  4
Affiliations
Review

Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease

Anna Och et al. Molecules. .

Abstract

In recent years, the health of patients exposed to the consequences of the metabolic syndrome still requires the search for new solutions, and plant nutraceuticals are currently being intensively investigated. Berberine is a plant alkaloid possessing scientifically determined mechanisms of the prevention of the development of atherosclerosis, type 2 diabetes, and obesity, as well as cardiovascular complications and cancer. It positively contributes to elevated levels of fasting, postprandial blood glucose, and glycosylated hemoglobin, while decreasing insulin resistance. It stimulates glycolysis, improving insulin secretion, and inhibits gluconeogenesis and adipogenesis in the liver; by reducing insulin resistance, berberine also improves ovulation. The anti-obesity action of berberine has been also well-documented. Berberine acts as an anti-sclerotic, lowering the LDL and testosterone levels. The alkaloid exhibits an anti-inflammatory property by stalling the expression of cyclooxygenase 2 (COX-2) and prostaglandin E2. Berberine is neuroprotective and acts as an antidepressive. However, the outcomes in psychiatric patients are nonspecific, as it has been shown that berberine improves metabolic parameters in schizophrenic patients, acting as an adjuvant during antipsychotic treatment. Berberine acts as an anticancer option by inducing apoptosis, the cell cycle arrest, influencing MAPK (mitogen-activated protein kinase), and influencing transcription regulation. The inhibition of carcinogenesis is also combined with lipid metabolism.

Keywords: atherosclerosis; berberine; cancer; cancer prevention; clinical trials; ischemic heart disease; metabolic syndrome; myocardial infarction; obesity; polycystic ovary syndrome; stroke; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Factors and processes that impact the development of the metabolic syndrome.
Figure 2
Figure 2
Potential berberine activity against the metabolic syndrome.
See this image and copyright information in PMC

References

    1. Eckel R.H., Grundy S.M., Zimmet P.Z. The Metabolic Syndrome. Lancet. 2005;365:1415–1428. doi: 10.1016/S0140-6736(05)66378-7. - DOI - PubMed
    1. Dietrich P., Hellerbrand C. Non-Alcoholic Fatty Liver Disease, Obesity and the Metabolic Syndrome. Best Pract. Res. Clin. Gastroenterol. 2014;28:637–653. doi: 10.1016/j.bpg.2014.07.008. - DOI - PubMed
    1. Sherling D.H., Perumareddi P., Hennekens C.H. Metabolic Syndrome. J. Cardiovasc. Pharmacol. Ther. 2017;22:365–367. doi: 10.1177/1074248416686187. - DOI - PubMed
    1. De la Iglesia R., Loria-Kohen V., Zulet M.A., Martinez J.A., Reglero G., Ramirez de Molina A. Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome. Int. J. Mol. Sci. 2016;17:1877. doi: 10.3390/ijms17111877. - DOI - PMC - PubMed
    1. Ganguli R., Strassnig M. Prevention of Metabolic Syndrome in Serious Mental Illness. Psychiatr. Clin. 2011;34:109–125. doi: 10.1016/j.psc.2010.11.004. - DOI - PubMed

MeSH terms